Skip to content
The Kids Research Institute Australia logo
Donate

Search

Showing results for "1"

News & Events

Environmental factors could trigger rise in type 1 diabetes

New research from Perth's Telethon Institute for Child Health Research has revealed an unexpected pattern in the rate and incidence of type 1 diabetes

Research

UVR exposure, Vitamin D and type 1 diabetes

Liz Prue Davis Hart MBBS FRACP PhD BSc (Hons) MSc PhD Co-director of Children’s Diabetes Centre Honorary Research Fellow prue.hart@thekids.org.au

News & Events

Insulin and Abatacept trial in type 1 diabetes

Diabetes researchers from The Kids Research Institute Australia and Perth Children’s Hospital are excited to be taking part in the national Insulin

News & Events

Type 1 diabetes National Screening Pilot launches in WA

Did you know that 9 out of 10 children diagnosed with type 1 diabetes have no family history of the condition?

News & Events

Type 1 diabetes in children - RTR FM interview

Did you catch Professor Liz Davis, co-director of the Children's Diabetes Centre and head of Perth Children's Hospital's endocrinology department, on RTR FM's Fitter Happier segment recently?

News & Events

New resources to help manage Type 1 Diabetes

A new series of educational films has been released for newly diagnosed Type 1 Diabetes patients and their families.

Research

IgE and IgG binding patterns and T-cell recognition of fel d 1 and Non-Fel d 1 cat allergens

To compare IgE and IgG antibody binding and T-cell recognition of the major cat allergen Fel d 1 with other cat proteins with known IgE binding properties.

Sport resources key to encouraging physical activity in youth living with type 1 diabetes

Sports coaches across Australia can now access WA-designed sport resources, which aim to help coaches better understand type 1 diabetes (T1D) and encourage children living with the condition to stay in sport.

Research

Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery

Rapid improvements in glucose control may lead to early worsening of diabetic retinopathy (EWDR). There is a need to demonstrate safety in people commencing automated insulin delivery (AID) due to the known efficacy in rapid glycemic improvement. We aimed to investigate short-term DR outcomes in people (aged ≥13 years) with type 1 diabetes after initiation of AID (use ≥6 months).